TRAF2 and osteoporosis: In osteoporosis, TRAF2 is thought to inhibit BMP signaling as TNF-α exposure results in decreased phospho-Smad1, BMPR-IA, and Runx2 levels, while BMPR-IB and BMPR-II levels increase.